Literature DB >> 25397780

Re: 'Fellow eye effect of unilateral intravitreal bevacizumab injection in eyes with diabetic macular edema'.

N S Sharma1, J M Ong1, J-L Ooi1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25397780      PMCID: PMC4330279          DOI: 10.1038/eye.2014.265

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  4 in total

1.  Fellow eye effect of unilateral intravitreal bevacizumab injection in eyes with diabetic macular edema.

Authors:  J Hanhart; L Tiosano; E Averbukh; E Banin; I Hemo; I Chowers
Journal:  Eye (Lond)       Date:  2014-05-23       Impact factor: 3.775

2.  Bilateral effect of unilateral ranibizumab in patients with uveitis-related macular edema.

Authors:  Nisha R Acharya; Wantanee Sittivarakul; Ying Qian; Kevin C Hong; Salena M Lee
Journal:  Retina       Date:  2011-10       Impact factor: 4.256

3.  Effects on the contralateral eye after intravitreal bevacizumab and ranibizumab injections: a case report.

Authors:  Ziqiang Wu; Srinivas R Sadda
Journal:  Ann Acad Med Singapore       Date:  2008-07       Impact factor: 2.473

4.  Comparison of the effect of unilateral intravitreal bevacizumab and ranibizumab injection on diabetic macular edema of the fellow eye.

Authors:  Berker Bakbak; Banu Turgut Ozturk; Saban Gonul; Mevlut Yilmaz; Sansal Gedik
Journal:  J Ocul Pharmacol Ther       Date:  2013-07-13       Impact factor: 2.671

  4 in total
  3 in total

1.  Fellow eye effect of unilateral intravitreal anti-VEGF injections in eyes with diabetic macular edema.

Authors:  J Hanhart; I Chowers
Journal:  Eye (Lond)       Date:  2014-11-14       Impact factor: 3.775

2.  Predictive Assessment of Quantitative Ultra-Widefield Angiographic Features for Future Need for Anti-VEGF Therapy in Diabetic Eye Disease.

Authors:  Alice C Jiang; Duriye Damla Sevgi; Christopher Mugnaini; Jon Whitney; Sunil K Srivastava; Katherine E Talcott; Ming Hu; Jamie L Reese; Justis P Ehlers
Journal:  J Pers Med       Date:  2022-04-10

3.  Evaluation of long-term intravitreal anti-vascular endothelial growth factor injections on renal function in patients with and without diabetic kidney disease.

Authors:  Rachael Ann O'Neill; Patrick Gallagher; Tricia Douglas; Julie-Anne Little; Alexander Peter Maxwell; Giuliana Silvestri; Gareth McKay
Journal:  BMC Nephrol       Date:  2019-12-26       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.